Detailed information for compound 1267601

Basic information

Technical information
  • TDR Targets ID: 1267601
  • Name: 2-chloro-N-[2-(2-morpholin-4-yl-2-oxoethyl)su lfanyl-1,3-benzothiazol-6-yl]benzamide
  • MW: 447.958 | Formula: C20H18ClN3O3S2
  • H donors: 1 H acceptors: 3 LogP: 3.84 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(N1CCOCC1)CSc1sc2c(n1)ccc(c2)NC(=O)c1ccccc1Cl
  • InChi: 1S/C20H18ClN3O3S2/c21-15-4-2-1-3-14(15)19(26)22-13-5-6-16-17(11-13)29-20(23-16)28-12-18(25)24-7-9-27-10-8-24/h1-6,11H,7-10,12H2,(H,22,26)
  • InChiKey: LFJFZDFFYIEEEN-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-chloro-N-[2-(2-morpholino-2-oxo-ethyl)sulfanyl-1,3-benzothiazol-6-yl]benzamide
  • 2-chloro-N-[2-[(2-morpholino-2-oxoethyl)thio]-1,3-benzothiazol-6-yl]benzamide
  • 2-chloro-N-[2-[(2-keto-2-morpholino-ethyl)thio]-1,3-benzothiazol-6-yl]benzamide
  • 2-chloro-N-[2-(2-morpholin-4-yl-2-oxo-ethyl)sulfanyl-1,3-benzothiazol-6-yl]benzamide
  • NCGC00118611-01
  • D336-0080

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.0167 1 1
Loa Loa (eye worm) hypothetical protein 0.0049 0.2041 0.2409
Onchocerca volvulus 0.0019 0 0.5
Echinococcus multilocularis geminin 0.0167 1 1
Schistosoma mansoni tar DNA-binding protein 0.0062 0.2939 0.2939
Brugia malayi MH2 domain containing protein 0.0144 0.8474 1
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.8474 1
Brugia malayi TAR-binding protein 0.0062 0.2939 0.3468
Brugia malayi RNA recognition motif domain containing protein 0.0062 0.2939 0.3468
Brugia malayi Calcitonin receptor-like protein seb-1 0.0049 0.2041 0.2409
Echinococcus granulosus tar DNA binding protein 0.0062 0.2939 0.2939
Loa Loa (eye worm) TAR-binding protein 0.0062 0.2939 0.3468
Schistosoma mansoni tar DNA-binding protein 0.0062 0.2939 0.2939
Echinococcus multilocularis tar DNA binding protein 0.0062 0.2939 0.2939
Plasmodium vivax cysteine repeat modular protein 1, putative 0.0019 0 0.5
Brugia malayi latrophilin 2 splice variant baaae 0.0034 0.0991 0.117
Brugia malayi RNA binding protein 0.0062 0.2939 0.3468
Loa Loa (eye worm) hypothetical protein 0.0034 0.0991 0.117
Schistosoma mansoni tar DNA-binding protein 0.0062 0.2939 0.2939
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0062 0.2939 0.3468
Leishmania major hypothetical protein, conserved 0.0019 0 0.5
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.8474 1
Schistosoma mansoni tar DNA-binding protein 0.0062 0.2939 0.2939
Brugia malayi Corticotropin releasing factor receptor 2 precursor, putative 0.0049 0.2041 0.2409
Schistosoma mansoni hypothetical protein 0.0034 0.0991 0.0991
Schistosoma mansoni tar DNA-binding protein 0.0062 0.2939 0.2939
Trypanosoma cruzi hypothetical protein, conserved 0.0019 0 0.5
Loa Loa (eye worm) RNA binding protein 0.0062 0.2939 0.3468
Loa Loa (eye worm) pigment dispersing factor receptor c 0.0049 0.2041 0.2409
Plasmodium falciparum cysteine repeat modular protein 1 0.0019 0 0.5
Schistosoma mansoni hypothetical protein 0.0167 1 1
Toxoplasma gondii kringle domain-containing protein 0.0019 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 11.2202 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 20.5962 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 21.3313 uM PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 79.4328 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.